Patents/Assignees

Resverlogix Corp.

1 patent in portfolio

US12551484utility2026
Methods of Treatment And/or Prevention of Major Adverse Cardiovascular Events (MACE) with a Combination of a BET Bromodomain Inhibitor and a Sodium Dependent Glucose Transport 2 Inhibitor
0 cites